scholarly article | Q13442814 |
P50 | author | Francesca Sarlo | Q56926253 |
Andrea Cabibbo | Q85911649 | ||
Antonino De Lorenzo | Q85911651 | ||
P2093 | author name string | Laura Di Renzo | |
Carmen Colica | |||
Santo Gratteri | |||
P2860 | cites work | Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method | Q74529698 |
Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity | Q85223826 | ||
Identification of the receptor component of the IkappaBalpha-ubiquitin ligase | Q22008569 | ||
Regional differences in cellular mechanisms of adipose tissue gain with overfeeding | Q24624643 | ||
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People | Q24633789 | ||
Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine | Q27024626 | ||
Surfing the p53 network | Q28032484 | ||
Increased nuclear proteins in muscle satellite cells in aged animals as compared to young growing animals | Q28577528 | ||
Maximal extraction of biological information from genetic interaction data | Q28755007 | ||
Obesity: preventing and managing the global epidemic. Report of a WHO consultation | Q29547404 | ||
p53 in health and disease | Q29619939 | ||
p53 mutant mice that display early ageing-associated phenotypes | Q29622826 | ||
SIRT1 undergoes alternative splicing in a novel auto-regulatory loop with p53. | Q33727892 | ||
Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality | Q33728251 | ||
Skeletal muscle loss: cachexia, sarcopenia, and inactivity | Q34099406 | ||
Waist circumference and not body mass index explains obesity-related health risk | Q34301193 | ||
Normal weight obese (NWO) women: an evaluation of a candidate new syndrome | Q34584574 | ||
Normal-weight obese syndrome: early inflammation? | Q34599163 | ||
Normal weight obesity is associated with metabolic syndrome and insulin resistance in young adults from a middle-income country. | Q34654065 | ||
Increased Plin2 expression in human skeletal muscle is associated with sarcopenia and muscle weakness | Q34974245 | ||
Gene expression profiles resulting from stable loss of p53 mirrors its role in tissue differentiation | Q35060929 | ||
Catabolism of aging: is it an inflammatory process? | Q35104886 | ||
Predicting the influence of multiple components on microbial inhibition using a logistic response model--a novel approach | Q35188026 | ||
Intramuscular adipose tissue, sarcopenia, and mobility function in older individuals | Q35829783 | ||
AccII polymorphism of the p53 gene | Q35872939 | ||
Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications | Q35926379 | ||
Codon 72 polymorphism (rs1042522) of TP53 is associated with changes in diastolic blood pressure over time | Q35969007 | ||
Molecular and cellular mechanisms of skeletal muscle atrophy: an update. | Q36179105 | ||
Intracellular signaling during skeletal muscle atrophy | Q36288224 | ||
Estimating the population attributable risk for multiple risk factors using case-control data | Q36499362 | ||
Association of body composition with sarcopenic obesity in elderly women | Q36558227 | ||
Women's higher health risks in the obesogenic environment: a gender nutrition approach to metabolic dimorphism with predictive, preventive, and personalised medicine | Q36575768 | ||
The p53 Codon 72 Polymorphism Modifies the Cellular Response to Inflammatory Challenge in the Liver | Q37120247 | ||
Obesity genes and gene-environment-behavior interactions: recommendations for a way forward | Q37244322 | ||
Subclinical vascular inflammation in subjects with normal weight obesity and its association with body fat: an 18 F-FDG-PET/CT study. | Q37714570 | ||
Mechanisms of muscle wasting in sarcopenia. | Q37998359 | ||
Role of the Crosstalk between Autophagy and Apoptosis in Cancer | Q38120523 | ||
The concept of normal weight obesity | Q38179549 | ||
Oxidative stress in normal-weight obese syndrome. | Q38345413 | ||
Body composition and -174G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome. | Q38359230 | ||
Systems pharmacology meets predictive, preventive, personalized and participatory medicine | Q39205321 | ||
Differential levels of transcription of p53-regulated genes by the arginine/proline polymorphism: p53 with arginine at codon 72 favors apoptosis. | Q39761795 | ||
Subcutaneous adipocyte size and body fat distribution | Q39827789 | ||
Systems biology and new technologies enable predictive and preventative medicine. | Q40473946 | ||
Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. | Q40767544 | ||
The role of wild-type p53 in the differentiation of primary hemopoietic and muscle cells | Q40922665 | ||
Defining the regulatory networks for muscle development. | Q41099976 | ||
p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells | Q41368682 | ||
A new predictive equation for evaluating women body fat percentage and obesity-related cardiovascular disease risk | Q42231576 | ||
p53 regulates myogenesis by triggering the differentiation activity of pRb. | Q42941221 | ||
Adiposity rather than BMI determines metabolic risk | Q44438006 | ||
Prevalence of sarcopenia based on different diagnostic criteria using DEXA and appendicular skeletal muscle mass reference values in an Italian population aged 20 to 80. | Q46890037 | ||
Prevalence of normal weight obesity in Switzerland: effect of various definitions | Q47226762 | ||
Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: relationship to body composition and IL-1 alpha and beta plasma levels. | Q47309657 | ||
Normal Weight Obese syndrome: role of single nucleotide polymorphism of IL-1 5Ralpha and MTHFR 677C-->T genes in the relationship between body composition and resting metabolic rate. | Q47313129 | ||
Body composition analyses in normal weight obese women. | Q47325574 | ||
Comparisons of waist circumferences measured at 4 sites | Q47614423 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | sarcopenia | Q1787939 |
P304 | page(s) | 743634 | |
P577 | publication date | 2014-10-13 | |
P1433 | published in | Disease Markers | Q15756044 |
P1476 | title | Individually tailored screening of susceptibility to sarcopenia using p53 codon 72 polymorphism, phenotypes, and conventional risk factors | |
P478 | volume | 2014 |
Q47363867 | Association of body composition and eating behavior in the normal weight obese syndrome. |
Q33785098 | Can psychobiotics intake modulate psychological profile and body composition of women affected by normal weight obese syndrome and obesity? A double blind randomized clinical trial |
Q97884559 | From obesity through gut microbiota to cardiovascular diseases: a dangerous journey |
Q26774656 | New obesity classification criteria as a tool for bariatric surgery indication |
Q90060498 | Obesity subtypes, related biomarkers & heterogeneity |
Q47725934 | Physical Activity and Nutrition INfluences In ageing (PANINI): consortium mission statement. |
Q92636627 | Prevention and Treatment of Sarcopenic Obesity in Women |
Q53193618 | Replication study of the vitamin D receptor (VDR) genotype association with skeletal muscle traits and sarcopenia. |
Q53700576 | The influence of diet on anti-cancer immune responsiveness. |
Q64275689 | Why primary obesity is a disease? |